Investments

A compelling and cheap investment

RBS building © Alamy

At first sight, this professional services business appears a decent investment story, but not a compelling one, says Max King. Yet dig a little deeper and it looks much better.

The next phase of shareholder activism

It’s no longer enough to research the investment methodology when choosing a fund, says Merryn Somerset Webb. You have to check its approach to ethics too.

If only you’d invested in: Village Farms

Canadian pot stocks have risen as high as kites in the wake of the legalisation of recreational cannabis in 2018, and the performance of Village Farms has been among the most impressive.

How to find a bargain in the British market

Richard Penny of the FP CRUX UK Special Situations Fund chooses three top-quality stocks.

Why you need to own gold

All the talk of Modern Monetary Theory misses one key point, says Eoin Treacy. We’re already well down the road of printing money to fund government spending.

Chart of the week: Greece – a better credit risk than the US?

The yield on the five-year Greek government bond has slipped beneath its US counterpart. For a country that has borrowed too much since its foundation to be considered a better credit risk than Uncle Sam seems absurd.

Emerging markets bounce back

Last year emerging market stocks fell by nearly a quarter, says Marina Gerner. But in 2019 it has been a different story.

Uber: pricey and unprofitable

The ride-hailing giant is gearing up for a flotation that will see it valued at $100bn. That looks very expensive. Matthew Partridge reports.

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

Maybe don't take a ride with Uber

There’s nothing remotely risqué in buying loss-making firms when they list, says Merryn Somerset Webb. But that doesn’t make it a good idea.

Looking for profits in eye care will pay off for investors

Vision care may not sound exciting, but it is an enormous market expanding quickly as ageing populations require more – and increasingly sophisticated – treatments, says Matthew Partridge.

Diploma qualifies for your portfolio

This British mid-cap is a successful global player with plenty of room for expansion, says Dr Mike Tubbs.

It’s time to look beyond London property

Central London has defied the gloomsters, but the regions look more buoyant for now.

If only you’d invested in: Marshalls

Marshalls makes concrete and stone paving for retail outlets and the construction industry, operating throughout the UK. Business has held up well despite the Brexit uncertainty.

How to track down cheap stockmarkets

One proven route to market-beating returns is to invest in cheap stocks, says John Stepek. But it’s a lot harder than it looks.

Fidelity is back on form

Alex Wright’s Special Values fund draws on Anthony Bolton’s techniques and is worth backing, says Max King.

It makes sense to lend to governments

No matter how ramshackle or indebted the country, buying its bonds is rarely a bad idea, says Matthew Lynn.

The charts that matter: US jobless figures finally hit a fresh low

The four-week moving average of weekly US jobless claims fell to 207,000, the lowest level in nearly 50 years. John Stepek looks at the chart as well as all of the others that matter most to investors.

Contrarian picks that promise big profits

Alec Cutler of Orbis Global Balanced Fund finds three stocks ripe with opportunity.

Chart of the week: will the oil rally last?

A disruption to supplies from the North African country could give oil prices a big short-term boost.

Debenhams is the latest retailer to go down

The group fell into administration this week, marking another setback for Sports Direct founder Mike Ashley. Matthew Partridge reports.

Investors head for India

Voting in the world’s largest election began this week in India and this time investors are looking forward to the results.

Share tips of the week

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK’s financial pages.

Sun comes back out on Wall Street

US stocks are going from strength to strength as improved data drives confidence. Marina Gerner reports.

A symptom of our quantitative-easing-addled world

That Saudi Arabian oil giant Saudi Aramco was able to borrow so cheaply on the markets is odd, says John Stepek.

The drugs don’t work: stopping the spread of the superbugs

Antibiotic resistance could turn medical inconveniences into death sentences and become a bigger killer than cancer. Governments and pharmaceutical companies are fighting back. Sarah Moore reports.

Showing page 1 of 562

disfi.com